https://live.ajibio.com/2017/12/14/the-government-of-flanders-recently-agreed-to-participate-in-ajinomoto-omnichems-investments-into-new-and-innovative-technologies/ 2026-08-01T20:49:04+00:00 https://live.ajibio.com/2017/10/10/on-the-22nd-september-2017-granules-omnichem-limited-goc-received-the-establishment-inspection-report-eir-from-the-us-fda/ 2026-08-04T15:46:50+00:00 https://live.ajibio.com/2017/10/01/louvain-la-neuve-new-address-from-01-10-2017/ 2026-08-04T16:08:56+00:00 https://live.ajibio.com/2017/09/19/ajinomoto-althea-inc-opens-manufacturing-suites-in-new-high-potency-and-antibody-drug-conjugate-commercial-facility/ 2026-08-04T16:09:56+00:00 https://live.ajibio.com/2017/08/24/ajinomoto-althea-inc-announces-new-aseptic-fill-finish-line/ 2026-08-04T16:10:33+00:00 https://live.ajibio.com/2017/07/24/ceo-j-david-enloe-awarded-most-admired-ceo/ 2026-08-04T16:11:28+00:00 https://live.ajibio.com/2017/04/13/ajinomoto-omnichem-launches-flow-chemistry-for-api-commercial-manufacturing/ 2026-08-04T16:12:14+00:00 https://live.ajibio.com/2017/04/14/ajinomoto-omnichem-launches-flow-chemistry-for-api-commercial-manufacturing-2/ 2026-08-04T16:14:02+00:00 https://live.ajibio.com/2016/12/18/ajinomoto-group-acquires-all-shares-of-genedesign-a-nucleic-acid-drug-cdmo-to-accelerate-expansion-of-the-contract-business-for-oligonucleotides/ 2026-08-04T16:14:44+00:00 https://live.ajibio.com/2016/10/04/biologics-candidate-manufactured-using-ajinomoto-co-inc-s-corynex-protein-expression-system-enters-clinical-trials-for-the-first-time/ 2026-08-04T16:15:55+00:00 https://live.ajibio.com/2016/05/17/ajinomoto-althea-inc-announces-issuance-of-new-us-patent-for-manufacturing-of-crystal-monoclonal-antibodies/ 2026-08-04T16:16:31+00:00 https://live.ajibio.com/2016/03/15/ajinomoto-althea-inc-expands-its-capacity-of-fill-finish-manufacturing-with-addition-of-second-shift/ 2026-08-04T16:17:12+00:00 https://live.ajibio.com/2015/12/10/ajinomoto-althea-inc-launches-process-and-analytical-development-services-for-antibody-drug-conjugates-adcs-therapeutics/ 2026-08-04T16:17:49+00:00 https://live.ajibio.com/2015/10/14/ajinomoto-althea-inc-expands-manufacturing-capabilities-to-adc-fill-finish-and-bioconjugation/ 2026-08-04T16:18:24+00:00 https://live.ajibio.com/2015/06/26/ajinomoto-althea-inc-awarded-ca-tax-credit/ 2026-08-04T16:18:59+00:00 https://live.ajibio.com/2015/06/16/ajinomoto-althea-inc-receives-european-gmp-certification-for-commercial-aseptic-filling-and-testing/ 2026-08-04T16:19:31+00:00 https://live.ajibio.com/2015/03/31/altheas-new-drug-formulation-technology-gains-attention-from-two-more-top-pharmaceutical-companies/ 2026-08-04T16:28:46+00:00 https://live.ajibio.com/2014/09/03/ajinomoto-althea-inc-receives-european-gmp-certification/ 2026-08-04T16:33:21+00:00 https://live.ajibio.com/2014/01/09/ajinomoto-althea-inc-now-offering-a-novel-protein-production-platform-corynex/ 2026-08-04T16:33:54+00:00 https://live.ajibio.com/2014/01/06/ajinomoto-althea-inc-appoints-j-david-enloe-as-president-and-chief-executive-officer/ 2026-08-04T16:34:28+00:00 https://live.ajibio.com/2013/11/04/ajinomoto-althea-inc-selected-as-a-finalist-in-26th-annual-connect-most-innovative-new-product-awards/ 2026-08-04T16:34:58+00:00 https://live.ajibio.com/2013/04/04/ajinomoto-co-inc-completes-acquisition-of-althea-technologies-inc/ 2026-08-04T16:35:35+00:00 https://live.ajibio.com/2013/03/06/ajinomoto-co-inc-agrees-to-acquire-althea-technologies-inc/ 2026-08-04T16:36:14+00:00 https://live.ajibio.com/2013/02/26/althea-technologies-profectus-biosciences-sign-manufacturing-agreement-for-plasmid-dna-production/ 2026-08-04T16:36:49+00:00 https://live.ajibio.com/2012/10/24/pfenex-inc-awards-althea-technologies-a-contract-for-cgmp-manufacturing-of-circumsporozoite-protein-from-plasmodium-falciparum-a-key-malaria-antigen/ 2026-08-04T16:37:23+00:00 https://live.ajibio.com/2012/09/24/althea-technologies-announces-expanded-roles-for-key-executives/ 2026-08-04T16:37:55+00:00 https://live.ajibio.com/2018/05/31/ajinomoto-althea-inc-announces-additions-to-management-team-as-it-transforms-into-a-global-cdmo/ 2026-08-04T16:38:31+00:00 https://live.ajibio.com/2018/10/02/ajinomoto-althea-and-omnichem-combine-to-form-ajinomoto-bio-pharma-services-reflecting-a-collective-range-of-services-offered-to-the-bio-pharma-industry/ 2026-08-04T16:39:15+00:00 https://live.ajibio.com/2018/10/23/precision-nanosystems-announces-manufacturing-collaboration-agreement-with-ajinomoto-bio-pharma-services-for-gmp-manufacturing-of-high-quality-nanomedicines/ 2026-08-04T16:39:46+00:00 https://live.ajibio.com/2018/11/28/ajinomoto-bio-pharma-services-introduces-ajicap-bioconjugation-technology-for-adc-manufacturing/ 2026-08-04T16:40:21+00:00 https://live.ajibio.com/2018/12/18/ajinomoto-and-xl-protein-forge-strategic-alliance-to-develop-pasylated-therapeutics-applying-the-corynex-platform/ 2026-08-04T16:40:54+00:00 https://live.ajibio.com/2019/03/12/ajinomoto-bio-pharma-services-announces-capital-expansion-to-fuel-growth/ 2026-08-04T16:41:24+00:00 https://live.ajibio.com/2019/04/03/jean-baptiste-agnus-joins-ajinomoto-bio-pharma-services-global-leadership-team-as-vice-president-of-sales-and-marketing/ 2026-08-04T16:41:54+00:00 https://live.ajibio.com/2019/04/09/genedesign-joins-ajinomoto-bio-pharma-services-and-opens-oligonucleotide-api-development-center/ 2026-08-04T16:42:24+00:00 https://live.ajibio.com/2019/08/29/ajinomoto-bio-pharma-services-acquires-remaining-interest-in-granules-omnichem-joint-venture-in-india/ 2026-08-04T16:42:58+00:00 https://live.ajibio.com/2020/03/10/ajinomoto-bio-pharma-services-announces-formation-of-external-advisory-board/ 2026-08-04T16:45:37+00:00 https://live.ajibio.com/2020/04/30/trio-pharmaceuticals-inc-and-ajinomoto-bio-pharma-services-enter-into-a-development-collaboration-for-a-novel-antibody-therapeutic/ 2026-08-04T16:46:37+00:00 https://live.ajibio.com/2020/05/05/ajinomoto-bio-pharma-services-announces-manufacturing-partnership-with-cytodyn-for-drug-product-used-in-covid-19-clinical-trials/ 2026-08-04T16:47:06+00:00 https://live.ajibio.com/2020/05/27/ajinomoto-bio-pharma-services-signs-manufacturing-agreement-with-humanigen-for-lenzilumab-currently-in-fda-approved-phase-iii-study-for-covid-19/ 2026-08-04T16:47:34+00:00 https://live.ajibio.com/2020/06/02/ajinomoto-bio-pharma-services-completes-acquisition-of-granules-omnichem-joint-venture-in-india/ 2026-08-04T16:48:04+00:00 https://live.ajibio.com/2020/06/30/ajinomoto-bio-pharma-services-introduces-ajility-fast-track-platform-for-drug-product-manufacturing/ 2026-08-04T16:48:34+00:00 https://live.ajibio.com/2020/08/13/ajinomoto-bio-pharma-services-expands-small-molecule-manufacturing-capabilities-at-its-india-facility/ 2026-08-04T16:49:02+00:00 https://live.ajibio.com/2020/09/29/ajinomoto-bio-pharma-services-and-dndi-partner-to-develop-critical-immunomodulator-for-cutaneous-leishmaniasis-therapeutic/ 2026-08-04T16:49:35+00:00 https://live.ajibio.com/2020/10/06/first-commercial-drug-manufactured-via-ajinomoto-bio-pharma-services-ajiphase-technology-receives-fda-approval/ 2026-08-04T16:50:04+00:00 https://live.ajibio.com/2020/12/22/ajinomoto-bio-pharma-services-and-revance-therapeutics-announce-manufacturing-agreement-for-supply-of-daxibotulinumtoxina-for-injection/ 2026-08-04T16:50:39+00:00 https://live.ajibio.com/2021/01/27/ajinomoto-bio-pharma-services-and-humanigen-expand-manufacturing-agreement-to-support-fill-finish-for-investigational-covid-19-therapeutic-lenzilumab-nearing-completion-of-phase-3-study/ 2026-08-04T16:51:13+00:00 https://live.ajibio.com/2021/03/29/ajinomoto-co-inc-and-bright-peak-therapeutics-inc-enter-into-a-research-collaboration-and-license-agreement-to-create-novel-immunocytokines/ 2026-08-04T16:51:43+00:00 https://live.ajibio.com/2021/03/30/ajinomoto-bio-pharma-services-expands-manufacturing-agreement-with-astrazeneca-to-include-drug-product-manufacturing/ 2026-08-04T16:52:13+00:00 https://live.ajibio.com/2021/05/25/ajinomoto-bio-pharma-services-expands-fill-finish-capacity-with-new-multi-purpose-fill-suite/ 2026-08-04T16:52:41+00:00 https://live.ajibio.com/2022/01/25/tony-oneill-joins-ajinomoto-bio-pharma-services-leadership-team-as-vice-president-of-compliance/ 2026-08-04T16:53:10+00:00 https://live.ajibio.com/2022/03/03/ajinomoto-bio-pharma-services-awarded-two-cmo-leadership-awards/ 2026-08-04T16:53:43+00:00 https://live.ajibio.com/2023/01/10/ajinomoto-and-exelixis-enter-into-a-license-agreement-to-discover-and-develop-novel-antibody-drug-conjugates-for-the-treatment-of-cancer/ 2026-08-04T16:54:13+00:00 https://live.ajibio.com/2023/02/22/ajinomoto-bio-pharma-services-successfully-develops-highly-functional-ancestral-rna-ligase/ 2026-08-04T16:54:51+00:00 https://live.ajibio.com/2023/03/14/ajinomoto-bio-pharma-services-awarded-three-cdmo-leadership-awards/ 2026-08-04T16:55:18+00:00 https://live.ajibio.com/2023/04/19/ajinomoto-bio-pharma-services-receives-fda-approval-for-high-potency-fill-line/ 2026-08-04T16:55:48+00:00 https://live.ajibio.com/2023/05/18/ajinomoto-bio-pharma-services-announces-leadership-changes-at-us-facility/ 2026-08-04T16:56:17+00:00 https://live.ajibio.com/2023/12/27/notice-regarding-joint-research-agreement-with-ribomic-inc/ 2026-08-04T16:56:49+00:00 https://live.ajibio.com/2024/03/12/ajinomoto-bio-pharma-services-garners-six-cdmo-leadership-awards-further-establishing-its-industry-excellence/ 2026-08-04T16:57:15+00:00 https://live.ajibio.com/2024/06/12/ajinomoto-bio-pharma-services-announces-the-approval-of-the-32nd-drug-product-at-their-san-diego-sterile-fill-finish-site/ 2026-08-04T16:57:44+00:00 https://live.ajibio.com/2024/09/05/leading-global-cdmo-ajinomoto-bio-pharma-services-joins-cmac-as-new-translation-to-industry-collaborator/ 2026-08-04T16:59:00+00:00 https://live.ajibio.com/2025/03/20/ajinomoto-bio-pharma-services-awarded-cdmo-leadership-awards/ 2026-08-04T16:59:33+00:00 https://live.ajibio.com/2025/04/24/ajinomoto-co-inc-to-sell-its-entire-equity-stake-in-ajinomoto-althea-a-us-based-aseptic-fill-finish-cdmo-completed-on-may-1-2025/ 2026-08-04T17:00:12+00:00 https://live.ajibio.com/2025/05/06/successful-extension-of-nucleic-acid-aptamer-pharmacokinetics-in-joint-research-by-ajinomoto-co-inc-and-ribomic-inc/ 2026-08-04T17:00:45+00:00 https://live.ajibio.com/2025/11/17/ajinomoto-bio-pharma-services-wins-best-adc-preclinical-publication-2024-award-for-ajicap-technology-at-2025-world-adc-awards/ 2026-08-04T17:02:48+00:00 https://live.ajibio.com/2026/03/31/nj-bio-inc-and-ajinomoto-bio-pharma-services-enter-into-collaboration-to-strengthen-support-for-antibody-drug-conjugate-development/ 2026-08-04T17:03:21+00:00 https://live.ajibio.com/2026/04/16/piramal-pharma-solutions-and-ajinomoto-bio-pharma-services-collaborate-to-support-adc-development-and-manufacturing/ 2026-08-04T17:03:59+00:00 https://live.ajibio.com/2019/04/09/information-on-service-brand-name-change/ 2026-08-04T18:54:10+00:00 https://live.ajibio.com/2019/09/02/information-accompanying-the-revision-of-the-consumption-tax-rate/ 2026-08-04T18:54:51+00:00 https://live.ajibio.com/2021/11/10/reminder-notice-on-email-address-domain-changing/ 2026-08-04T18:56:23+00:00 https://live.ajibio.com/2025/10/31/ajinomoto-co-inc-enters-licensing-agreement-with-astellas-pharma-inc-for-biopharmaceutical-development-and-manufacturing-technology/ 2026-09-08T17:11:58+00:00 https://live.ajibio.com/2024/07/04/regarding-the-problem-with-the-inquiry-form-resolved-on-july-4th/ 2026-09-14T08:47:57+00:00 https://live.ajibio.com/2025/10/28/ajinomoto-bio-pharma-services-and-olon-s-p-a-form-strategic-partnership-to-advance-large-scale-peptide-and-protein-manufacturing/ 2026-09-14T08:48:31+00:00 https://live.ajibio.com/2025/10/21/ajinomoto-bio-pharma-services-and-gene-tools-announce-collaboration-to-expand-access-to-pmo-therapeutics/ 2026-09-14T08:48:57+00:00 https://live.ajibio.com/2024/11/29/notice-of-phone-outage-due-to-power-interruption/ 2026-09-14T08:49:28+00:00 https://live.ajibio.com/2024/10/07/notice-of-discontinuation-of-certain-products-and-services/ 2026-09-14T08:50:05+00:00 https://live.ajibio.com/2020/11/09/notice-on-email-address-domain-changing/ 2026-09-14T08:51:14+00:00 https://live.ajibio.com/2022/01/11/notice-on-email-address-for-business-use-changing/ 2026-09-14T08:52:10+00:00 https://live.ajibio.com/2026/03/02/notice-of-office-closure-2/ 2026-09-15T00:04:18+00:00 https://live.ajibio.com/2026/07/08/notice-of-office-closure-3/ 2026-09-15T00:05:40+00:00 https://live.ajibio.com/2026/06/23/notice-of-appointment-of-directors/ 2026-09-15T00:08:27+00:00 https://live.ajibio.com/2021/11/22/notice-on-email-address-changing/ 2026-09-15T00:24:06+00:00 https://live.ajibio.com/2026/04/21/impact-of-the-current-situation-in-the-middle-east-on-our-manufacturing-operations/ 2026-09-16T02:56:43+00:00 https://live.ajibio.com/2025/11/27/notice-of-office-closure/ 2026-09-16T02:57:31+00:00 https://live.ajibio.com/2023/07/21/notice-regarding-the-display-of-consumption-tax-under-japans-invoice-system/ 2026-09-16T03:23:03+00:00 https://live.ajibio.com/2022/09/26/notice-of-qualified-invoice-issuer-registration-number/ 2026-09-16T03:24:10+00:00